Recent Updates
Recently added Catalysts
CHRS Positive Sentiment

Coherus Management to Present at the TD Cowen 5th Annual Oncology Innovation Virtual Summit: Insights for ASCO & EHA

Thursday, May 23, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Coherus BioSciences has announced that its senior management will present at the upcoming TD Cowen 5th Annual Oncology Innovation Virtual Summit on May 29, 2024. The presentation will focus on insights for ASCO & EHA and will be accessible via a webcast. The event underscores Coherus' involvement in oncology and its ongoing commitment to sharing information with the investment community.
Price reaction · baseline $2.11 (2024-05-22 close) · hit after-hours · clean, no other CHRS news in the window
day 0 close · peak
-4.7%

Market Sentiment Analysis

POSITIVE FACTORS

  • Coherus is actively participating in a prominent oncology summit.
  • The presentation is expected to share valuable insights related to ASCO & EHA.
  • The event highlights Coherus' engagement in the field and its commitment to innovation.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+136%
120-day peak, hindsight
Typical move
6.6%
average across 12 past catalysts
Cash runway
~5 mo
High dilution risk
Lead asset
CHS-0214
Phase 3 · Rheumatoid Arthritis

Full Press Release Details

REDWOOD CITY, Calif., May 23, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Coherus, Nasdaq: CHRS) today announced that senior management will present at the upcoming TD Cowen 5th Annual Oncology Innovation Virtual Summit: Insights for ASCO & EHA on Wednesday, May 29, 2024 at 12:00 p.m. Eastern Daylight Time / 9:00 a.m. Pacific Daylight Time. The presentation will be accessible via Webcast through a link on the Investor Events and Presentations section of the Coherus website: https://investors.coherus.com/events-presentations. This webcast will be available for replay until June 26, 2024.
Coherus Contact Information:

Frequently Asked Questions

When will Coherus present at the TD Cowen Oncology Summit?

Coherus will present on May 29, 2024, at 12:00 p.m. EDT.

How can I access Coherus's presentation?

The presentation will be accessible via a webcast on their website.

Is there a replay available for the Coherus presentation?

Yes, the replay will be available until June 26, 2024.

Where is Coherus BioSciences located?

Coherus BioSciences is located in Redwood City, California.

What is the Nasdaq symbol for Coherus?

Coherus is listed on Nasdaq under the symbol CHRS.

ShareAdd on Google
Tags: CHRS Viatris Investor Conferences Healthcare Coherus Oncology Innovation Summit ASCO EHA
Last updated: May 23, 2024

Biotech snapshot

Cash runway
$105M liquidity · $21M/mo burn
~5 mo
High dilution risk
Lead asset
CHS-0214Phase 3
Rheumatoid Arthritis →

Catalyst track record

+136%
best trade around CHRS's most recent catalyst

Peak hindsight return over a 120-day window, across 12 tracked FDA/PDUFA catalysts for CHRS.

See every catalyst's timing & PoA →